周四盘中，港股荣昌生物（09995.HK）股价大涨6.34%，引发市场关注。分析显示，这波涨势很可能与持续的南向资金流入有关。
根据最新数据，南向资金连续3个交易日增持荣昌生物。4月2日单日增持146.40万股，截至当日收盘，港股通共持有荣昌生物7455.20万股，占流通股的39.32%。这表明内地投资者对该股票保持较高热情。
值得注意的是，荣昌生物近期表现强劲。过去5个交易日，该股累计上涨33.00%，港股通在此期间增持550.10万股；而在近20个交易日里，涨幅更是达到58.02%，港股通累计增持840.54万股。这种持续的买入行为和股价上涨趋势相互呼应，进一步推动了股价的上扬。尽管有报告显示该股存在一定程度的卖空活动，但目前看来，多头力量占据上风。投资者应密切关注该股后市走向，并谨慎评估相关风险。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.